Insulin Glargine 4002 Study Investigators: The Treat-to-Target Trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. - Riddle,M.; Rosenstock,J.; Gerich,J. (Diabetes Care, 2003)